A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Beijing Biotech
Amgen
Neonc Technologies, Inc.
xCures
Adela, Inc
Var2 Pharmaceuticals
Novartis
Merck Sharp & Dohme LLC
Massive Bio, Inc.
AVM Biotechnology Inc
LigaChem Biosciences, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Apollomics Inc.
Tempus AI
Aminex Therapeutics, Inc.
Taproot Health
NGM Biopharmaceuticals, Inc
Quadriga Biosciences, Inc.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Shenzhen BinDeBio Ltd.
Novartis
SpeciCare
Shenzhen BinDeBio Ltd.
INSYS Therapeutics Inc
Pharmacyclics LLC.